NCT06618391 2024-10-01
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT03008109 2017-01-04
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC
Air Force General Hospital of the PLA
Phase 3 Unknown
NCT00576914 2010-03-09
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
Chinese Academy of Sciences
Phase 3 Unknown